This inventor holds 2 USPTO granted patents. Top assignees: Isis Innovation Limited, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2007-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2007-2010
Title: Werner Hoch: Innovator in Neurotransmission Disorders
Introduction
Werner Hoch is a notable inventor based in Houston, TX (US), recognized for his contributions to the field of neuroscience. He holds 2 patents that focus on diagnosing neurotransmission and developmental disorders in mammals. His innovative methods have the potential to significantly impact medical diagnostics and treatment.
Latest Patents
Hoch's latest patents involve a method for diagnosing neurotransmission or developmental disorders. This method includes detecting autoantibodies to an epitope of the muscle-specific tyrosine kinase (MuSK) in a bodily fluid of a mammal. The process comprises two main steps: first, contacting the bodily fluid with MuSK or an antigenic determinant thereof; and second, detecting any antibody-antigen complexes formed. The presence of these complexes indicates that the mammal may be suffering from neurotransmission or developmental disorders. Additionally, Hoch has developed kits for use in the diagnosis of these disorders.
Career Highlights
Throughout his career, Werner Hoch has worked with prestigious organizations, including the Max Planck Society for the Advancement of Science and Isis Innovation Limited. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.
Collaborations
Hoch has collaborated with notable professionals, including Angela Vincent, enhancing the quality and impact of his research. Their joint efforts have focused on improving diagnostic methods for complex neurological conditions.
Conclusion
Werner Hoch's innovative work in diagnosing neurotransmission disorders showcases his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving healthcare outcomes for individuals affected by these conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile